We are live on
!
Find out more
ELC
Edgar Lomax Company Portfolio holdings
AUM
$1.4B
1-Year Est. Return
20.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.49B
AUM Growth
-$66.3M
(-4.3%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-6.32%
Top 10 Holdings %
Top 10 Hldgs %
42.89%
Holding
71
New
5
Increased
30
Reduced
21
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$58.6M |
| 2 |
AT&T
T
|
+$49.5M |
| 3 |
IBM
IBM
|
+$43.7M |
| 4 |
Coca-Cola
KO
|
+$43.2M |
| 5 |
Procter & Gamble
PG
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$77.4M |
| 2 |
Merck
MRK
|
+$64.4M |
| 3 |
Chevron
CVX
|
+$53.2M |
| 4 |
Wells Fargo
WFC
|
+$37.3M |
| 5 |
Target
TGT
|
+$34.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.11% |
| 2 | Financials | 15.51% |
| 3 | Consumer Staples | 13.82% |
| 4 | Healthcare | 11.5% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Occidental Petroleum
OXY
$55.6B
| $8.59M | 0.58% |
135,624
+29,412
| +28% | +$1.96M |
|
|
52
Target
TGT
$65.6B
| $7.39M | 0.49% |
133,900
-555,553
| -81% | -$34.6M |
|
53
Altria Group
MO
$113B
| $5.31M | 0.36% |
74,326
-20
| -0% | -$1.45K |
|
54
iShares S&P 500 Value ETF
IVE
$49.1B
| $880K | 0.06% |
8,454
| – | – |
|
55
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $774K | 0.05% |
3,282
| – | – |
|
56
Berkshire Hathaway Class A
BRK.A
$1.1T
| $500K | 0.03% |
2
| – | – |
|
57
Markel Group
MKL
$23.4B
| $254K | 0.02% |
260
| – | – |
|
58
Accenture
ACN
$99.9B
| – | – |
-2,900
| Closed | -$340K |
|
59
American International
AIG
$41.8B
| – | – |
-362,900
| Closed | -$23.7M |
|
60
ConocoPhillips
COP
$145B
| – | – |
-153,455
| Closed | -$7.69M |
|
61
Devon Energy
DVN
$50.9B
| – | – |
-397,450
| Closed | -$18.2M |
|
62
Gilead Sciences
GILD
$163B
| – | – |
-222,142
| Closed | -$15.9M |
|
63
Halliburton
HAL
$26.4B
| – | – |
-420,995
| Closed | -$22.8M |
|
64
Kinder Morgan
KMI
$70.5B
| – | – |
-460,370
| Closed | -$9.53M |
|
65
Mondelez International
MDLZ
$80.5B
| – | – |
-559,836
| Closed | -$24.8M |
|
66
Norfolk Southern
NSC
$75B
| – | – |
-148,040
| Closed | -$16M |
|
|
67
UnitedHealth
UNH
$383B
| – | – |
-483,770
| Closed | -$77.4M |
|
|
68
Wells Fargo
WFC
$258B
| – | – |
-677,274
| Closed | -$37.3M |
|
Similar funds
FCP
TWM
AI
IAS
EA
QC
SCM
SP
Edgar Lomax Company's Q1 2017 Portfolio in Review
As of Q1 2017, Edgar Lomax Company held 71 positions worth $1.49B, down 4.3% from $1.56B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Edgar Lomax Company withdrew a net $94.4M in Q1 2017, closing 11 positions and reducing 21 holdings. Its most notable exit was UnitedHealth, an estimated $77.4M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Edgar Lomax Company opened a new position in Bank of America worth $22.7M.
- Edgar Lomax Company's largest Q1 2017 buy was Bank of America: 962,410 shares worth $22.7M.
- Edgar Lomax Company added most to CVS Health in Q1 2017, an estimated $58.6M increase.
- Edgar Lomax Company's biggest Q1 2017 reduction was Merck, cutting an estimated $64.4M.
- Edgar Lomax Company fully exited UnitedHealth in Q1 2017, selling an estimated $77.4M.
- Edgar Lomax Company's ten largest holdings make up 43% of its $1.49B portfolio in Q1 2017.
- Edgar Lomax Company opened 5 new positions and closed 11 in Q1 2017.
- Edgar Lomax Company's portfolio value fell 4.3% quarter-over-quarter to $1.49B.
Based on Edgar Lomax Company's 13F filing for Q1 2017, filed 12 May 2017.